JPWO2019157458A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019157458A5
JPWO2019157458A5 JP2020542437A JP2020542437A JPWO2019157458A5 JP WO2019157458 A5 JPWO2019157458 A5 JP WO2019157458A5 JP 2020542437 A JP2020542437 A JP 2020542437A JP 2020542437 A JP2020542437 A JP 2020542437A JP WO2019157458 A5 JPWO2019157458 A5 JP WO2019157458A5
Authority
JP
Japan
Prior art keywords
benzodiazole
fluoro
pyridin
pyridine
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020542437A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021512889A5 (https=
JP2021512889A (ja
JP7365347B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/017529 external-priority patent/WO2019157458A1/en
Publication of JP2021512889A publication Critical patent/JP2021512889A/ja
Publication of JP2021512889A5 publication Critical patent/JP2021512889A5/ja
Publication of JPWO2019157458A5 publication Critical patent/JPWO2019157458A5/ja
Application granted granted Critical
Publication of JP7365347B2 publication Critical patent/JP7365347B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020542437A 2018-02-12 2019-02-11 ソマトスタチンモジュレーターおよびその使用 Active JP7365347B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201862629377P 2018-02-12 2018-02-12
US62/629,377 2018-02-12
US201862673042P 2018-05-17 2018-05-17
US62/673,042 2018-05-17
US201862724421P 2018-08-29 2018-08-29
US62/724,421 2018-08-29
PCT/US2019/017529 WO2019157458A1 (en) 2018-02-12 2019-02-11 Somatostatin modulators and uses thereof

Publications (4)

Publication Number Publication Date
JP2021512889A JP2021512889A (ja) 2021-05-20
JP2021512889A5 JP2021512889A5 (https=) 2022-02-21
JPWO2019157458A5 true JPWO2019157458A5 (https=) 2022-02-21
JP7365347B2 JP7365347B2 (ja) 2023-10-19

Family

ID=67548490

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020542437A Active JP7365347B2 (ja) 2018-02-12 2019-02-11 ソマトスタチンモジュレーターおよびその使用

Country Status (5)

Country Link
US (1) US11608335B2 (https=)
EP (1) EP3752498B1 (https=)
JP (1) JP7365347B2 (https=)
MA (1) MA51840A (https=)
WO (1) WO2019157458A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018170284A1 (en) 2017-03-16 2018-09-20 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
EP3752498B1 (en) 2018-02-12 2023-06-28 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
AR116424A1 (es) 2018-09-18 2021-05-05 Crinetics Pharmaceuticals Inc Moduladores de la somatostatina y usos de los mismos
TWI841768B (zh) 2019-08-14 2024-05-11 美商克林提克斯醫藥股份有限公司 非肽生長抑制素(somatostatin)5型受體激動劑及其用途
EP4294797A1 (en) 2021-02-17 2023-12-27 Crinetics Pharmaceuticals, Inc. Crystalline forms of a somatostatin modulator
CA3207382A1 (en) * 2021-02-17 2022-08-25 Christine FERRARA-COOK Somatostatin receptor type 5 agonist for the treatment of hyperinsulinism
AU2023366475A1 (en) * 2022-10-28 2025-05-29 Exelixis, Inc. Somatostatin receptor 2 agonists and uses thereof
JP2026500913A (ja) 2022-12-13 2026-01-09 クリネティックス ファーマシューティカルズ,インク. ソマトスタチンサブタイプ-2受容体(sst2r)標的化治療薬及びその使用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127343A (en) 1996-05-14 2000-10-03 Novo Nordisk A/S Somatostatin agonists and antagonists
US6025372A (en) 1997-04-04 2000-02-15 Merck & Co., Inc. Somatostatin agonists
FR2802206B1 (fr) 1999-12-14 2005-04-22 Sod Conseils Rech Applic Derives de 4-aminopiperidine et leur utilisation en tant que medicament
US20060281764A1 (en) 2005-06-10 2006-12-14 Gaul Michael D Aminopyrimidines as kinase modulators
CA2644929A1 (en) * 2006-03-13 2008-05-02 Merck & Co., Inc. Somatostatin agonists
EP2054385A2 (en) 2006-08-15 2009-05-06 F. Hoffmann-Roche AG Phenyl, pyridine and quinoline derivatives
EP2211619A1 (en) 2007-10-18 2010-08-04 Merck Sharp & Dohme Corp. Substituted 1,2,4-oxadiazoles and analogs thereof as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases
CA2729220A1 (en) 2008-06-25 2009-12-30 Envivo Pharmaceuticals, Inc. Di-substituted phenyl compounds
GB0818241D0 (en) 2008-10-06 2008-11-12 Cancer Res Technology Compounds and their use
CA2772194A1 (en) 2009-09-01 2011-03-10 Pfizer Inc. Benzimidazole derivatives
CA2799414A1 (en) 2010-05-18 2011-11-24 Merck Sharp & Dohme Corp. Spiro isoxazoline compounds as sstr5 antagonists
GB201008290D0 (en) 2010-05-18 2010-06-30 Syngenta Ltd Chemical compounds
WO2014007228A1 (ja) * 2012-07-03 2014-01-09 小野薬品工業株式会社 ソマトスタチン受容体作動活性を有する化合物およびその医薬用途
AU2014325078B2 (en) * 2013-09-30 2018-10-25 Ono Pharmaceutical Co., Ltd. Compound having agonistic activity to somatostatin receptor and medicinal use thereof
CN105579524B (zh) 2013-10-02 2018-05-04 株式会社可乐丽 树脂组合物、多层片、包装材料和容器
HRP20221279T1 (hr) 2016-07-14 2022-12-23 Crinetics Pharmaceuticals, Inc. Modulatori somatostatina i njihove uporabe
CN110300749A (zh) 2017-02-08 2019-10-01 小野药品工业株式会社 具有生长抑素受体激动活性的化合物及其医药用途
WO2018170284A1 (en) * 2017-03-16 2018-09-20 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
US11028068B2 (en) 2017-07-25 2021-06-08 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
EP3752498B1 (en) 2018-02-12 2023-06-28 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
AR116424A1 (es) 2018-09-18 2021-05-05 Crinetics Pharmaceuticals Inc Moduladores de la somatostatina y usos de los mismos
TWI841768B (zh) 2019-08-14 2024-05-11 美商克林提克斯醫藥股份有限公司 非肽生長抑制素(somatostatin)5型受體激動劑及其用途

Similar Documents

Publication Publication Date Title
JP2021512889A5 (https=)
RU2317291C2 (ru) Производные пиримидина в качестве модуляторов рецептора инсулинподобного фактора роста 1 (igf-1), фармацевтическая композиция, способы получения (варианты) и применение
JP2019518036A5 (https=)
JP3930560B2 (ja) 炎症の処置のための1,2−置換イミダゾリル化合物
RU2492167C2 (ru) Производные аминотриазола в качестве агонистов alх
RU2006127420A (ru) Новое 2-гетероарил-замещенное производное бензимидазола
JP2018535999A5 (https=)
RU2016141646A (ru) Ингибиторы trka киназы, основанные на них композиции и способы
JP2018530591A5 (https=)
RU2019132212A (ru) Селективные ингибиторы hdac6
JP2007531752A5 (https=)
HRP20170506T1 (hr) Dihidropiridon p1 kao inhibitori xia faktora
IL258577A (en) 2,4-dihydroxy-nicotinamides as apj agonists
JP2019537571A5 (https=)
RU2016108753A (ru) Ингибиторы ферментов
JP2020533347A5 (https=)
JP2015533157A5 (https=)
JP2014511869A5 (https=)
RU2011153788A (ru) Гетероциклические противовирусные соединения
JPWO2019157458A5 (https=)
RU2015122698A (ru) Производное пиридина
CA2575003A1 (en) Potassium channel inhibitors
RU2017118562A (ru) Соединения-антагонисты дофаминового d3-рецептора
RU2003115612A (ru) Производные амидоалкилпиперидинов и амидоалкилпиперазинов, пригодные для лечения нарушений нервной системы
JP2018521119A5 (https=)